Eli Lilly will increase the UK list price of Mounjaro (tirzepatide) from £92–£122 to £133–£330 per month starting 1 September. The change comes amid US pressure on drugmakers to adjust international pricing and aims to align UK prices more closely with other developed markets. Lilly confirmed NHS access will be maintained, but private patients may face significant cost increases. Industry experts warn this may signal a broader trend of rising medicine prices in the UK and Europe in 2026.

Read the full article for details on pricing strategy and market impact.

Read the full article here.